CRISPR技術市場規模、佔有率和成長分析（按產品/服務、應用、最終用戶和地區分類）—產業預測（2026-2033年）

全球 CRISPR 技術市場預計到 2024 年價值為 35 億美元，到 2025 年將成長至 40.8 億美元，到 2033 年將成長至 138.4 億美元，預測期（2026-2033 年）複合年成長率為 16.5%。

受基因組編輯技術進步的推動，全球CRISPR技術市場正經歷顯著成長。這項革命性的工具能夠對DNA序列進行精確修改，使研究人員能夠解決基因缺陷、對抗疾病並提高農業生產力。 CRISPR利用合成的引導RNA和Cas9核酸酶，實現標靶基因組修飾，包括基因元件的移除或插入。 CRISPR在微生物學領域的應用不斷擴展，加上基因研究投入的不斷增加，進一步增強了其市場潛力。然而，儘管市場成長迅速，但倫理考量和專業知識匱乏等挑戰可能會阻礙其進一步擴張。 CRISPR的應用範圍涵蓋疾病治療到農業改良，凸顯了其在現代生物技術和基因工程中的重要角色。

全球 CRISPR 技術市場促進因素

全球CRISPR技術市場的成長受到多種因素的推動，這些因素共同促進了基因編輯領域的發展。北美和歐洲等已開發地區對基因研究的資金投入不斷增加，大大推動了市場擴張。這些地區政府主導的舉措，促使對基因發現所需的創新材料、先進設備和新技術進行大量投資。此外，這些資金也推動了罕見遺傳疾病醫療解決方案的研發。同時，歐洲國家人類基因組研究所等機構的支持，在推動基因組研究方面發揮關鍵作用，進一步鞏固了市場潛力。

限制全球CRISPR技術市場的因素

全球CRISPR技術市場面臨許多限制因素，主要源自於CRISPR治療方法的高成本。開發和生產先進的基因編輯治療方法需要大量的時間、資源和投資，導致成本增加。由於CRISPR基因檢測試劑盒和治療方案的價格限制了其普及，最終這些經濟負擔會轉嫁到病人身上。因此，高成本阻礙了這項創新技術的廣泛應用，也為CRISPR市場的整體成長和覆蓋範圍帶來了挑戰，使其難以服務於需要基因介入的各類人群。

全球CRISPR技術市場趨勢

將人工智慧 (AI) 和機器學習 (ML) 應用於基因編輯流程是全球 CRISPR 技術市場的一大趨勢。這種融合透過改進靶點識別和最大限度地減少脫靶效應，提高了 CRISPR 應用的準確性和效率。憑藉先進的數據分析能力，AI 和 ML 正在加速藥物研發和診斷等各領域的治療標靶發現過程。隨著這些技術的不斷發展，它們有望進一步革新基因編輯，推動研發創新，拓展潛在應用範圍，從而顯著促進 CRISPR 市場的成長。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管分析

全球 CRISPR 技術市場規模（按產品/服務分類）及複合年成長率（2026-2033 年）

• 產品
  • CRISPR試劑盒和酶
  • CRISPR文庫
  • 其他產品
  • 設計工具
  • 抗體
  • 其他試劑
• 服務
  • gRNA設計與載體構建
  • 細胞株工程
  • 篩檢服務
  • 表觀基因編輯
  • 轉錄活化
  • 其他

全球 CRISPR 技術市場規模：按應用和複合年成長率 (2026-2033)

• 藥物發現與開發
• 農業
• 其他
  • 生質燃料
  • 獸醫學

全球 CRISPR 技術市場規模（按最終用戶分類）及複合年成長率（2026-2033 年）

• 製藥和生物技術公司
• 學術和研究機構
• 其他
  • CRO
  • CDMO

全球 CRISPR 技術市場規模（按地區分類）及複合年成長率（2026-2033 年）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• CRISPR Therapeutics（Switzerland/USA）
• Intellia Therapeutics（USA）
• Editas Medicine（USA）
• Beam Therapeutics（USA）
• Mammoth Biosciences（USA）
• Caribou Biosciences（USA）
• Synthego（USA）
• ERS Genomics（Ireland）
• Takara Bio（Japan）
• Merck KGaA（Germany）
• Thermo Fisher Scientific（USA）
• Danaher Corporation（Integrated DNA Technologies（IDT））（USA）
• Horizon Discovery（PerkinElmer Inc.）（UK/USA）
• GenScript（USA）
• Agilent Technologies（USA）
• New England Biolabs（USA）
• Cellectis（France）
• Sangamo Therapeutics（USA）
• Addgene（USA）
• Biocytogen Co., Ltd.（China）

結論與建議

Global CRISPR Technology Market size was valued at USD 3.50 Billion in 2024 and is poised to grow from USD 4.08 Billion in 2025 to USD 13.84 Billion by 2033, growing at a CAGR of 16.5% during the forecast period (2026-2033).

The global CRISPR technology market is experiencing significant growth driven by advancements in genome editing capabilities. This revolutionary tool enables precise modifications of DNA sequences, allowing researchers to address genetic defects, combat diseases, and enhance agricultural yields. By leveraging synthetic guide RNA and Cas9 nuclease, CRISPR facilitates targeted genomic alterations, including the removal or insertion of genetic components. The rising application of CRISPR in microbiology, coupled with increasing investments in genetic research, reinforces its market potential. Despite this growth, ethical considerations and a scarcity of specialized knowledge present challenges that could hinder further expansion. Applications range from disease treatment to agricultural improvements, highlighting CRISPR's crucial role in modern biotechnology and genetic engineering.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global CRISPR Technology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global CRISPR Technology Market Segments Analysis

Global CRISPR Technology Market is segmented by Product, Application, End User and region. Based on Product, the market is segmented into Products and Services. Based on Application, the market is segmented into Drug discovery & development, Agriculture and Other applications. Based on End User, the market is segmented into Pharmaceutical & biotechnology companies, Academic & research institutes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global CRISPR Technology Market

The growth of the global CRISPR technology market is driven by a multitude of factors that enhance the gene editing sector. An uptick in financial support for genetic research in developed regions like North America and Europe is significantly bolstering market expansion. Government initiatives in these areas are channeling substantial investments into innovative materials, advanced equipment, and novel techniques for genetic exploration. Additionally, such funding fosters the advancement of medical solutions targeting rare genetic disorders. Furthermore, support from entities like the National Human Genome Research Institute in Europe plays a crucial role in propelling genomics research forward, further solidifying the market's potential.

Restraints in the Global CRISPR Technology Market

The Global CRISPR Technology market faces significant constraints primarily due to the high costs associated with CRISPR-based therapies. Developing and manufacturing advanced genome editing treatments require extensive time, resources, and investment, leading to increased expenses. This financial burden ultimately falls on patients, as the accessibility of CRISPR gene detection kits and therapeutic options is limited by their price. Consequently, the high costs hinder widespread adoption and utilization of these innovative technologies, posing a challenge to the overall growth and reach of the CRISPR market as it seeks to serve a diverse population in need of genetic interventions.

Market Trends of the Global CRISPR Technology Market

The Global CRISPR Technology market is witnessing a significant trend towards the integration of artificial intelligence (AI) and machine learning (ML) into gene editing processes. This fusion enhances the precision and efficiency of CRISPR applications by improving target identification and minimizing off-target effects. Leveraging advanced data analysis capabilities, AI and ML are accelerating the therapeutic target discovery process within various sectors, including drug development and diagnostics. As these technologies evolve, they are expected to further revolutionize gene editing, fostering innovation in research and expanding the range of potential applications, thereby driving substantial growth in the CRISPR market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis

Global CRISPR Technology Market Size by Product & Services & CAGR (2026-2033)

• Market Overview
• Products
  • CRISPR kits & Enzymes
  • CRISPR Libraries
  • Other Products
  • Design Tools
  • Antibodies
  • Other Reagents
• Services
  • GRNA Design & Vector Construction
  • Cell Line Engineering
  • Screening Services
  • Other Services
  • Epigenome Editing
  • Transcriptional Activation

Global CRISPR Technology Market Size by Application & CAGR (2026-2033)

• Market Overview
• Drug discovery & development
• Agriculture
• Other applications
  • Biofuels
  • Veterinary

Global CRISPR Technology Market Size by End User & CAGR (2026-2033)

• Market Overview
• Pharmaceutical & biotechnology companies
• Academic & research institutes
• Others
  • CROs
  • CDMOs

Global CRISPR Technology Market Size & CAGR (2026-2033)

• North America (Product & Services, Application, End User)
  • US
  • Canada
• Europe (Product & Services, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Services, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Services, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Services, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• CRISPR Therapeutics (Switzerland/USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intellia Therapeutics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Editas Medicine (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beam Therapeutics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mammoth Biosciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Caribou Biosciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synthego (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ERS Genomics (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (Integrated DNA Technologies (IDT)) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Horizon Discovery (PerkinElmer Inc.) (UK/USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellectis (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sangamo Therapeutics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Addgene (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocytogen Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations